Skip to content

Nelfinavir and nevirapine well tolerated during pregnancy

Risk factors for cardiovascular disease increased in HIV-positive women

Once-daily Kaletra approved for treatment-naive patients in USA (corrected)

Underestimating necessity for HAART, and concerns about side-effects, leads to low uptake and poor adherence

Travelling on HAART, particularly to the US, a 'negative practical and emotional experience.'

Stopping smoking only factor associated with improvement in cardiovascular risk amongst French HIV patients

Interleukin-2 causes bigger CD4 responses with more treatment cycles and undetectable viral load

Expert says HIV drugs give only 5-10 year window to come up with new ways to beat AIDS in Africa

BHIVA issues draft 2005 treatment guidelines, calls for comments by May 3rd